Vaccine maker says it will soon share interim results of study with FDA and global regulators

Centers for Disease Control and Prevention will consult an expert panel Thursday before finalizing official recommendations for who should get boosters and when

European Medicines Agency rules to approve 3rd shots of Pfizer-BioNTech's coronavirus inoculation for all people aged over 18

European Medicines Agency will rule in early October if to approve 3rd shots of the Pfizer coronavirus vaccine for all people aged over 16

Stephane Bancel says COVID shots will be okayed for infants and there will be enough doses by mid-2022 to inoculate everyone worldwide; thinks situation could come to resemble flu

Accumulating research suggests vaccine's superiority, possibly due to dosage level -- 100 micrograms against 30 -- or dosage interval, with Pfizer given 3 weeks apart and Moderna 4

Mayo Clinic research finds both inoculations have dropped in efficacy, but Pfizer's decline has been much steeper; both remain highly effective against severe illness

But pharma CEO warns that Delta variant of coronavirus 'is a significant new threat,' though booster candidates show efficacy against mutation

Health Ministry chief says he hopes there'll be a new Pfizer shipment next month, allowing inoculation campaign to continue; expresses satisfaction at number of teens now immune

With Pfizer shots set to expire at end of July, no more first doses will be given to ages 12-15, possibly until September; adults can continue to get Moderna shots